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Over a 5%-year period, 22 of 262 children receiving liver transplants developed 
adenoviral infections. Five had adenoviral hepatitis in the allograft, caused by 
serotype 5. All five were treated for rejection, either just before or at the time of 
infection. Liver biopsy specimens had characteristic histological appearance, 
and diagnosis of adenoviral infection was confirmed with monoclonal anti-
adenoviral antibodies, electron microscopy, and by culture of liver tissue. In the 
remaining 17 patients, adenovirus was isolated from urine, stool, throat secre-
tions, and/or blood samples, but none had any detectable visceral infection. 
Serotypes 1 and 2 predominated, similar to children not receiving transplants 
during the same time period. Three of the patients with hepatitis are alive and 
well; two died of liver failure. Adenoviral hepatitis did not recur in the second 
allograft of a patient who underwent retransplantation for combined rejection and 
adenoviral hepatitis, and appears, therefore, not to be a contraindication to 
retransplantation when liver failure ensues. 
SINCE they were first isolated from 
human tissues in 1953, I adenoviruses 
(A V s) have been shown to cause a wide 
spectrum of illness. Common forms of 
infection are pharyngitis, conjunctivi-
tis, gastroenteritis, and pneumonia. It 
is believed that AV s cause 10% of pneu-
monias that require hospitalization in 
children2 and that by age 5 years every 
child has had at least one episode of AV 
infection. 3 Th date, 41 serotypes have 
been identified,' and serotypes 1 to 3, 
5 to 7, and 21 are the most common 
pathogens in children. 2 Adenoviruses 
have been reported on occasion to cause 
fulminant hepatitis and other dissemi-
nated infections, mostly in immunocom-
promised patients, 6-7 including renal 
and bone marrow transplant recipi-
ents. 8-12 There is a case report of a lethal 
AV infection following a fetal liver 
transplant for severe combined immu-
nodeficiency. 13 A recent fatal AV hepati-
tis following orthotopic liver transplant 
in a child in our institution prompted us 
to review our experience with these 
infections in pediatric recipients of 
orthotopic liver transplants. 
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METHODS 
The records of the virology labora-
tory at Children's Hospital of Pitts-
burgh were reviewed and all patients, 
including those receiving liver trans-
plants from whom AV was isolated be-
tween March 1981 and September 1986 
were identified. Clinical data of all pa-
tients with orthotopic liver transplants 
having AV infections were reviewed, 
with particular attention paid to the 
interval between transplantation and 
onset of infection, the relationship of 
rejection and its treatment to infection, 
other concomitant viral infections, and 
the clinical features of AV infections. All 
available, pertinent pathology material 
was reviewed by one of us (R.J.). Infor-
mation regarding the site and serotype 
of AV was obtained for the nontrans-
plant population. 
Viral Procedures 
Throat swab, urine, and blood spec-
imens were sent for virologic culture 
every two weeks in all children with 
liver transplants as part of viral surveil-
lance and during the investigation of 
any febrile episode (temperature of 
38.5°C or more). Stool samples were 
sent only when patients developed diar-
rhea. Beginning in June 1985, liver 
tissue from biopsy specimens was sent 
routinely for viral culture. Urine and 
throat swab specimens were sent in 
viral transport medium containing a 
balanced salt solution, gelatin, and anti-
biotics. Blood was sent in a heparinized 
specimen tube; the buffy coat was sepa-
rated and resuspended in viral trans-
port medium. Liver tissue , submitted in 
a petri dish with saline, was ground 
with a mortar and centrifuged and the 
supernatant was added to viral trans-
port medium. Specimens in viral trans-
port medium were inoculated into com-
mercially prepared cell culture tubes . 
One tube each of African green monkey 
kidney and HEp-2 cells and two tubes of 
human foreskin fibroblasts were used. 
Liver tissue was also inoculated into 
Rhesus monkey kidney and WI-38 cells. 
Cell culture tubes were maintained at 
37°C and observed periodically for cyto-
pathic effects. Cytomegalovirus (CMV) 
and herpes simplex were identified by 
their cytopathic effect alone. Suspected 
AV isolates were identified and typed at 
the Allegheny County (Pittsburgh) 
Laboratories using neutralization with 
antisera obtained from the Centers for 
Disease Control, on African green 
monkey kidney and HEp-2 cells. 
Pathological Studies 
Liver tissue was processed for light 
microscopy and a portion was snap 
frozen in a cryoprotective medium and 
stored at -70°C. Frozen sections were 
stained using an avidin-biotin perox-
idase method with monoclonal anti-AV 
antibody (MA805) and anti-CMV anti-
body (MA810). The anti-AV antibody 
crossreacts with all serotypes and the 
anti-CMV antibody recognized an early 
antigen. Appropriate biologic positive 
and negative controls were used. Sec-
tions for electron microscopy were fixed 
in 2% glutaraldehyde, embedded in ep-
oxy resin and examined with a Phillips 
II microscope. 
RESULTS 
During the 5Y2-year study period 262 
children received orthotopic liver trans-
plants. Immunosuppression was with 
cyclosporin and steroids. Rejection epi-
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sodes were treated with additional 
steroids, monoclonal antibody OKT3, or 
both. Twenty-two patients (8.4%) had 
AV isolated from different sites. These 
patients were divided into two groups 
based on the type of infection_ 
Group 1 
All five patients in this group (Table 1) 
had hepatitis caused by AV serotype 5 
(AV5) within an interval of 12 to 30 days 
following the transplant. All five had 
received treatment for suspected rejec-
tion either concurrently with the AV 
infection or shortly preceding it. Three 
of the five had the rejection episode 
treated with OKT3 in addition to other 
therapy. Four of the five patients 
showed growth of AVo in other sites in 
addition to liver (blood, urine, and 
throat), but none had any other paren-
chymal organ involvement. Two of the 
five also had CMV infection while in 
three A V was the only viral infection. 
All had elevated serum transaminase 
levels and severe systemic symptoms 
(eg, temperatures to 40°C and chills) 
but only in one could the fevers be 
attributed entirely to AV as the others 
had, in addition, rejection or other in-
fections. The diagnosis in all five was 
suspected by histological findings (four 
Table 1.-0ata on Patients With AV* Hepatitis Following Liver Transplantation 
Serum Aspartate 
Interval OKT3 Amlnotransferase/ VIrus Culture AV 
From Monoclonal AlanIne Seen on of LIver Isolated 
OLT No.t/ Transplant Antibody AmInotransferase Electron BIopsy From Other 
Age/Sex to InfectIon, d Therapy Values at DiagnosIs, UlL Microscopy SpecImen Sites 




74213 ylF 15 Yes 79138 Yes AVs AVs 
urine 
37918 ylF 30 No 314189 Not done AVs AVs 
blood. 
urine 
24612'12 ylM 25 No 1481132 Yes AVs None 




*AV Indicates adenovirus. 
tOrthotopic liver transplant (OLn case number assigned to the patient in Ihe liver transptant register. 
biopsy specimens and one hepatectomy 
specimen at retransplantation), and was 
confirmed by ancillary means. The pa-
tient undergoing retransplantation had 
both AV infection and rejection in the 
removed allograft. Three of the five 
patients are alive and well; two patients 
died of fulminant liver failure with coag-
ulopathy and of gastrointestinal tract 
bleeding. Autopsies were performed on 
both. 
The features in all five cases were 
highly distinctive and virtually identi-
cal. Punched-out, circumscribed lesions 
were scattered randomly in the hepatic 
parenchyma with no fixed relation to 
portal areas (Fig 1, left). These lesions 
had some necrosis but less than that 
seen in herpetic lesions. Instead, they 
were filled with monocytes and neu-
trophils (Fig 1, center), confirmed by 
the demonstration of large amounts of 
lysozyme in the mononuclear and gran-
ular cells (Fig 1, right) and with mono-
clonal antibody FMC-17 against mono-
cytes-macrophages. Very few T cells 
were seen in the lesions, using the pan 
T-cell marker, Til. 
Hepatocytes at the edges of the le-
sions were slightly enlarged without 
multinucleation. Only a few cells con-
tained intranuclear inclusions , most of 
which were stellate or cruciate ampho-
philic bodies (Fig 2, left). Monoclonal 
antibody to AV was intensely reactive 
with the nucleus and cytoplasm of cells 
in and around the lesions but with few 
cells outside of the lesions (Fig 2, right). 
Fig 1.-Adenovirus hepatitis. Left, Fairly circumscribed, punched-out lesions are filied with inflammatory celis (hematoxylin-eosin, 
original magnification x 97). Center, tnflammatory celi population consists of cells with oval or. segmented nuclei: Necrosis .is not 
conspicuous and nuclear inclusions may be hard to find (hematoxyhn-eosm, original. magmhcatlon x 250). Hight, Stalnmg of 
inflammatory celis with anti lysozyme reveals dense, nongranular cytoplasmiC distribution characteristic of monocytes 
(diaminobenzidine, original magnification x 330). 
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Fig 2,-Adenovirus hepatitis, Left, Case 1 (autopsy), infected nuclei are larger than uninfected ones, Nuclear 
"inclusions" consist of a patchwork of waxy-appearing dense material with unstained clear zones (1 f!,m) 
(polychrome, original magnification x 330), Right, Case 1 (biopsy specimen) frozen section of liver with a 
granuloma. Section has been stained with antiadenovirus monoclonal antibody, revealing dense reaction 
product in enlarged hepatocytes (amino-ethylcarbazol, original magnification x 97). 
There was no reaction with antibody to 
herpes simplex or CMV except in one 
instance (to be described later), In one 
child who died of AV hepatitis, autopsy 
results three days after biopsy showed 
progression with a far greater number 
of punched-out lesions, extensive, 
almost confluent necrosis, and fewer 
monocytes and neutrophiJs_ No AV was 
detected by microscopy outside of the 
liver. In the second patient, who died 15 
days after diagnosis, autopsy results 
showed extensive hepatic necrosis, but 
only a minimal amount of viral antigen 
was demonstrable in liver tissue and no 
other organ involvement was detected, 
Adenovirus was confirmed in the le-
sions by immunostaining of frozen liver 
tissue in the four cases tested (Fig 2, 
right). Viral particles 65 to 90 nm in size 
were seen in the four cases examined by 
electron microscopy. Adenovirus and 
CMV were found together in one lesion. 
In this instance, characteristic necrotiz-
ing lesions were found in which CMV 
was demonstrable by microscopy and 
confirmed by immunostaining. Since 
this type of granulomatous, monocyte-
filled lesion is not characteristic of CMV 
infection, another virus was suspected 
and AV was detected in the lifted sec-
tions . Adenovirus serotype 5 was 
cultured from liver biopsy specimens in 
all five patients, 
Group 2 
Seventeen patients aged 8 months 
through 10 years had AVon culture of 
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different body fluids (urine, stool, 
throat secretions, and/or blood), but 
without any detectable visceral infec-
tion (Table 2). One was a preoperative 
throat specimen. The other 16 devel-
oped infection five days to two years 
following orthotopic liver transplants. 
Seven had AV\ isolates, four, AV2; two, 
AV 5; and one , AV 7' In three patients the 
AV isolate was untyped. Nine of 17 had 
other viral infections (CMV, six; herpes 
simplex, two; and Epstein-Barr virus, 
three). Eleven of the 17 had liver biop-
sies close to the time of the A V isolation, 
but none showed hepatitis. Eleven of 
these 17 patients are alive and well. One 
has chronic rejection; two patients who 
earlier had Epstein-Barr virus infec-
tions developed Epstein-Barr virus-re-
lated lymphoproliferative disorders. 




During the study period there were 
47 AV isolates from 43 patients (Table 
3). Of the isolates, AV, and AV2 formed 
45%, and AVo formed 7%. 
COMMENT 
The incidence of AV infections in our 
patients was 8.4%. This could be an 
underestimate, because viral cultures 
were not pursued aggressively in the 
investigation of a febrile episode earlier 
on. Also, the use of other media, such as 
primary or transformed human embry-
Table 2.-Clinical Characteristics of 17 Patients in 
Group 2 Who Had AV' Infections Without Hepatitis 
Clinical Characteristics 
Fever 
Other viral infections 
Use of OKT3 before AV infection 
Rejection before AV infection 
AV, and AV2 isolates 
AV isolated from single site 
(throat, 6; urine, 5; stool, 1) 
AV isolated from multiple sites 
*AV indicates adenovirus. 










Table 3.-Pattern of AV' Isolates in Children Not 
Receiving Transplantst 
AV Site of No. of 
Serotypes:t Isolation Isolates 
AV, Pharynx, 6 10 
Stool,4 
AV2 Pharynx. 4 9 
Lymph node, 1 
Stool,4 
AV3 Pharynx, 5 6 
Stool,l 
AVs Urine, 1 3 
Stool , 2 




AVa Pharynx, 3 11§ 
Conjunctiva, 8 
Untyped AV Pharynx, 1 4 
Conjunctiva, 1 
Stool,2 
Total Isolates 47 
*AV indicates adenovirus. 
tBetween January 1981 and September 1986 al the 
virology laboratory of the Children's Hospital of Pitts-
burgh. 
~AsI and AV2 accounted for 45% of identified 
serotypes; and AVs, 7% of identified serotypes. §These were a clusler of cases in 1986. 
onic kidney cells for viral isolation may 
have yielded a higher incidence of 
positive cultures. The same applies to 
the culturing of liver tissue. The inci-
dence of AV hepatitis was 1. 9%, but it is 
possible that some were missed because 
it is very difficult to differentiate 
clinically between rejection and hepati-
tis, and some patients with hepatitis 
may not have undergone biopsy, Shields 
et al lO noted a 4.9% overall incidence of 
A V infections in 1051 bone marrow re-
cipients of all ages. Visceral infections 
accounted for 0.95%; two of those had 
AV hepatitis. 
Percutaneous liver biopsy is the most 
definitive way of diagnosing AV hepati-
tis. Without this, it may be mistakenly 
treated as rejection, with detrimental 
effects. The histological features of AV 
hepatitis reported in the literature have 
been those of advanced disease,6,6, 14 
showing considerable necrosis. The his-
tological appearance we have described 
is thus characteristic, allowing a 
presumptive diagnosis to be made on 
morphological grounds alone. This can 
be confirmed rapidly and economically 
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by immunoenzyme staining using 
monoclonal anti-AV antibodies. Elec-
tron microscopy is not required rou-
tinely. The diagnosis can be made 
within hours, long before viral cultures 
of the liver biopsy specimen are defini-
tive, which may take several days. 
All hepatitis cases in our series were 
due to A V,. Experimentally, human A V 5 
has been shown to cause fulminant hep-
atitis in newborn hamsters and mice. 15,16 
Some of the AV hepatitis cases reported 
in the literature were also caused by 
AV,.7,ID,1I Thus, AV, may have greater 
propensity to cause hepatitis than other 
serotypes, at least in children. 
The significance of the A V isolations 
in group 2 patients is not clear. Even 
though several of these patients had 
fevers, it is difficult to attribute them 
solely to AV infections, as other causes 
coexisted. It can be argued that some of 
these are not new AV infections but are 
episodes of temporary virus shedding 
following an AV infection in the recent 
past. This has been shown to happen 
following enteric and respiratory AV 
infections in normal children. 17 
The serotypes isolated in group 2 are 
similar to the pattern of isolates in the 
general pediatric population, where 
AV, and AV2 accounted for 60% of iso-
lates.2 In contrast to the studies of 
Shields et a1'° in bone marrow trans-
plants, and Horowitz et al,18 in patients 
with the acquired immunodeficiency 
syndrome, we did not find any AV 35 iso-
lates at all. We do not know at present 
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